Press Release January 5, 2022Moderna Announces First Participant Dosed in Phase 1 Study of its mRNA Epstein-Barr Virus (EBV) Vaccine 0 0 Share
Company Ticker News January 5, 2022Moderna begins Phase 1 study of its Epstein-Barr virus vaccine candidate 0 0 Share
Company Ticker News January 5, 2022Tesla and Moderna Started 2022 Very Differently. What History Says Happens Next. 0 0 Share
Company Ticker News January 5, 2022Moderna to Present at the Goldman Sachs 14th Annual Healthcare CEOs Unscripted Conference 0 0 Share
Company Ticker News January 4, 2022Moderna shipped 800 million COVID vaccines last year, more than tripled its cash position but stock falls again 0 0 Share
Press Release January 3, 2022Moderna to Provide Business and Pipeline Updates at the 2022 J.P. Morgan Healthcare Conference 0 0 Share